Manufacturer of Controlled Substances; Notice of Registration; Noramco, Inc., 5500-5501 [2013-01600]

Download as PDF 5500 Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: January 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Dated: January 15, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Manufacturer of Controlled Substances, Notice of Application; Siegfried (USA) [FR Doc. 2013–01603 Filed 1–24–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration mstockstill on DSK4VPTVN1PROD with Manufacturer of Controlled Substances; Notice of Registration; Ampac Fine Chemicals, LLC By Notice dated September 20, 2012, and published in the Federal Register on October 2, 2012, 77 FR 60145, AMPAC Fine Chemicals, LLC, Highway 50 and Hazel Avenue, Building 05001, Rancho Cordova, California 95670, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Tapentadol (9780), a basic class of controlled substance listed in schedule II. The company plans to manufacture the listed controlled substance for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a), and determined that the registration of AMPAC Fine Chemicals, LLC to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated AMPAC Fine Chemicals, LLC to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems; verification of the company’s compliance with state and local laws; and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. VerDate Mar<15>2010 18:39 Jan 24, 2013 Jkt 229001 [FR Doc. 2013–01534 Filed 1–24–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 19, 2012, Siegfried (USA), 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Tapentadol (9780), a basic class of controlled substance listed in schedule II. The company plans to manufacturer the listed controlled substance for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than March 26, 2013. Dated: January 15, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–01591 Filed 1–24–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Chemic Laboratories, Inc. By Notice dated September 25, 2012, and published in the Federal Register on October 2, 2012, 77 FR 60144, Chemic Laboratories, Inc., 480 Neponset Street, Building 7, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II. The company plans to manufacture small quantities of the above listed controlled substance for distribution to its customers for the purpose of research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a), and determined that the registration of Chemic Laboratories, Inc., to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Chemic Laboratories, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems; verification of the company’s compliance with state and local laws; and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: January 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–01535 Filed 1–24–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Noramco, Inc. By Notice dated October 9, 2012, and published in the Federal Register on October 18, 2012, 77 FR 64143, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801– 4417, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Codeine-N-oxide (9053) ............... Dihydromorphine (9145) ............... Morphine-N-oxide (9307) ............. Amphetamine (1100) .................... Methylphenidate (1724) ................ Phenylacetone (8501) .................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ E:\FR\FM\25JAN1.SGM 25JAN1 Schedule I I I II II II II II II 5501 Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices Drug Schedule Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Opium extracts (9610) .................. Opium fluid extract (9620) ............ Opium tincture (9630) .................. Opium, powdered (9639) ............. Opium, granulated (9640) ............ Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Tapentadol (9780) ........................ II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Noramco, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: January 15, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Cerilliant Corporation By Notice dated August 17, 2012, and published in the Federal Register on August 29, 2012, 77 FR 52366, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: [FR Doc. 2013–01600 Filed 1–24–13; 8:45 am] BILLING CODE 4410–09–P mstockstill on DSK4VPTVN1PROD with Drug Schedule Cathinone (1235) ......................................................................................................................................................................................... Methcathinone (1237) .................................................................................................................................................................................. 4-Methyl-N-methylcathinone (1248) ............................................................................................................................................................ N-Ethylamphetamine (1475) ........................................................................................................................................................................ N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. Fenethylline (1503) ...................................................................................................................................................................................... Aminorex (1585) .......................................................................................................................................................................................... 4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... Methaqualone (2565) .................................................................................................................................................................................. 1-Pentyl-3-(1-naphthoyl)indole (7118) ......................................................................................................................................................... 1-Butyl-3-(1-naphthoyl)indole (7173) ........................................................................................................................................................... 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole (7200) ............................................................................................................................. Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol] (7297) ..................................................................................................... 5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol] (7298) ......................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... Marihuana (7360) ........................................................................................................................................................................................ Tetrahydrocannabinols (7370) ..................................................................................................................................................................... Parahexyl (7374) ......................................................................................................................................................................................... Mescaline (7381) ......................................................................................................................................................................................... 3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. 2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ 2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ 3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine (7401) .................................................................................................................................. N-Hydroxy-3,4-methylendioxyamphetamine (7402) .................................................................................................................................... 3,4-Methylendioxy-N-ethylamphetamine (7404) .......................................................................................................................................... 3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ 4-Methoxyamphetamine (7411) ................................................................................................................................................................... 5-Methoxy-N-N-dimethyltryptamine (7431) ................................................................................................................................................. Alpha-methyltryptamine (7432) ................................................................................................................................................................... Bufotenine (7433) ........................................................................................................................................................................................ Diethyltryptamine (7434) ............................................................................................................................................................................. Dimethyltryptamine (7435) .......................................................................................................................................................................... Psilocybin (7437) ......................................................................................................................................................................................... Psilocyn (7438) ............................................................................................................................................................................................ 5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... N-Benzylpiperazine (7493) .......................................................................................................................................................................... VerDate Mar<15>2010 18:39 Jan 24, 2013 Jkt 229001 PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 E:\FR\FM\25JAN1.SGM 25JAN1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 78, Number 17 (Friday, January 25, 2013)]
[Notices]
[Pages 5500-5501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01600]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Noramco, Inc.

    By Notice dated October 9, 2012, and published in the Federal 
Register on October 18, 2012, 77 FR 64143, Noramco, Inc., 500 Swedes 
Landing Road, Wilmington, Delaware 19801-4417, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
Dihydromorphine (9145).....................  I
Morphine-N-oxide (9307)....................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Phenylacetone (8501).......................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II

[[Page 5501]]

 
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium extracts (9610)......................  II
Opium fluid extract (9620).................  II
Opium tincture (9630)......................  II
Opium, powdered (9639).....................  II
Opium, granulated (9640)...................  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Noramco, Inc., to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Noramco, Inc., to ensure that the company's registration 
is consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-01600 Filed 1-24-13; 8:45 am]
BILLING CODE 4410-09-P